Items where authors include "McCullagh, I."

Jump to: Article
Number of items: 6.

Article

Dark, P., Hossain, A., McAuley, D.F. et al. (543 more authors) (2025) Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. Journal of the American Medical Association (JAMA), 333 (8). pp. 682-693. ISSN 0098-7484

Sandoe, J.A.T. orcid.org/0000-0003-0193-8677, Grozeva, D. orcid.org/0000-0003-3239-8415, Albur, M. et al. (138 more authors) (2024) A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19. Journal of Antimicrobial Chemotherapy, 79 (11). pp. 2792-2800. ISSN 0305-7453

Webb, E.J.D. orcid.org/0000-0001-7918-839X, Howdon, D., Bestwick, R. et al. (132 more authors) (2024) The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study. Journal of Antimicrobial Chemotherapy, 79 (8). pp. 1831-1842. ISSN 0305-7453

Webb, E.J.D. orcid.org/0000-0001-7918-839X, Howdon, D., Bestwick, R. et al. (132 more authors) (2024) The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study. Journal of Antimicrobial Chemotherapy, 79 (8). ISSN 0305-7453

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

This list was generated on Wed Apr 2 15:00:38 2025 BST.